Literature DB >> 4261554

Bactericidal action of streptomycin and comparison with spectinomycin in heterozygotes of Escherichia coli.

P F Sparling, B D Davis.   

Abstract

Str(s)/str(r) heterozygotes of Escherichia coli K-12 are shown to be sensitive to the lethal as well as the inhibitory action of streptomycin. The rate of killing was lower in heterozygotes than in sensitive homozygotes, and among heterozygotes it was lower in those with a higher proportion of resistant ribosomes. These strains also differed, in a parallel manner, in the kinetics of inhibition of growth and protein synthesis by streptomycin. Similar results were obtained with spectinomycin and corresponding merodiploid strains. Since spectinomycin is purely bacteriostatic and stabilizes polysomes, it must block resistant ribosomes behind inhibited sensitive ribosomes; hence, these results are consistent with an initial similar polysomal blockade by streptomycin. However, since streptomycin causes gradual polysome breakdown, its dominant lethal action must involve some mechanism other than a permanent polysomal blockade.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4261554      PMCID: PMC444201          DOI: 10.1128/AAC.1.3.252

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Ribosomes from Escherichia coli merodiplods heterozygous for resistance to streptomycin and to spectinomycin.

Authors:  P F Sparling; J Modolell; Y Takeda; B D Davis
Journal:  J Mol Biol       Date:  1968-11-14       Impact factor: 5.469

2.  Effect of spectinomycin on polypeptide synthesis in extracts of Escherichia coli.

Authors:  P Anderson; J Davies; B D Davis
Journal:  J Mol Biol       Date:  1967-10-14       Impact factor: 5.469

3.  Rapid inhibition of polypeptide chain extension by streptomycin.

Authors:  J Modolell; B D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1968-12       Impact factor: 11.205

4.  Three genes that affect Escherichia coli ribosomes.

Authors:  D Apirion
Journal:  J Mol Biol       Date:  1967-12-14       Impact factor: 5.469

5.  Ribosomal ambiguity.

Authors:  L Gorini; G A Jacoby; L Breckenridge
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1966

Review 6.  Revised linkage map of Escherichia coli.

Authors:  A L Taylor; C D Trotter
Journal:  Bacteriol Rev       Date:  1967-12

7.  The dominance of streptomycin sensitivity re-examined.

Authors:  L Breckenridge; L Gorini
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

8.  Polyribosome depletion and blockage of the ribosome cycle by streptomycin in Escherichia coli.

Authors:  L Luzzatto; D Apirion; D Schlessinger
Journal:  J Mol Biol       Date:  1969-06-14       Impact factor: 5.469

9.  Mechanism of inhibition of ribosomes by streptomycin.

Authors:  J Modolell; B D Davis
Journal:  Nature       Date:  1969-10-25       Impact factor: 49.962

10.  Inhibition of protein synthesis by spectinomycin.

Authors:  J Davies; P Anderson; B D Davis
Journal:  Science       Date:  1965-09-03       Impact factor: 47.728

View more
  5 in total

1.  Ribosomal mutation affecting the streptomycin phenotype of str A1 str A+ merodiploids in E. coli.

Authors:  D K Biswas
Journal:  Mol Gen Genet       Date:  1974-05-31

2.  Aminoglycoside resistance with homogeneous and heterogeneous populations of antibiotic-resistant ribosomes.

Authors:  M I Recht; J D Puglisi
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

3.  Separation of the SOS-dependent and SOS-independent components of alkylating-agent mutagenesis.

Authors:  L B Couto; I Chaudhuri; B A Donahue; B Demple; J M Essigmann
Journal:  J Bacteriol       Date:  1989-08       Impact factor: 3.490

4.  Selective inhibition of initiating ribosomes by spectinomycin.

Authors:  B J Wallace; P C Tai; B D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

Review 5.  New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Roman Manetsch; George A O'Doherty; James E Kirby
Journal:  Transl Res       Date:  2020-03-02       Impact factor: 7.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.